Key Players Driving the Malaria Vaccine Market: GSK vs. Serum Institute of India
The Malaria Vaccine Market is currently defined by two major players and their respective vaccines, creating a dynamic competitive landscape. GlaxoSmithKline (GSK) developed and launched the first-ever WHO-recommended malaria vaccine, RTS,S/AS01, brand-named Mosquirix. Its successful pilot programs demonstrated the feasibility and impact of a malaria vaccine in real-world settings, paving the way for a broader rollout. GSK's vaccine laid the foundation for the entire market by proving that a malaria vaccine could be a vital public health tool.
The market has since welcomed a new, highly promising competitor: the R21/Matrix-M vaccine, developed by the University of Oxford and manufactured by the Serum Institute of India (SII). The R21 vaccine is notable for its higher reported efficacy in trials and its potential for more cost-effective, large-scale production. This new entrant promises to address the long-standing issue of supply constraints, as SII has the capacity to produce a massive volume of doses. The introduction of…
.png)

The electric vehicle finance market is rapidly advancing as lenders embrace digital innovation and sustainability. Collaboration with EV manufacturers and fintech platforms enhances efficiency and customer satisfaction.
Engaging an ERP customization consultant can further optimize financial operations, automate loan management, and integrate data analytics—helping lenders deliver seamless, personalized financing solutions in this fast-evolving, eco-driven market landscape.